SEC Form 3 · accession 0000899243-18-018172
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bart W Wise
Officer — SVP, Legal Affairs
Period of report
Jun 21, 2018
Accepted (ET)
Jun 26, 2018 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,647 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $11.87 | holding | — | — | — | — | Dec 31, 2025 | Common Stock | 75,000 | — | D |
| Employee Stock Option (right to buy)F2 | $9.09 | holding | — | — | — | — | Jan 8, 2026 | Common Stock | 5,890 | — | D |
| Employee Stock Option (right to buy)F3 | $2.97 | holding | — | — | — | — | Jan 3, 2027 | Common Stock | 37,500 | — | D |
| Employee Stock Option (right to buy)F4 | $9.30 | holding | — | — | — | — | Jan 4, 2028 | Common Stock | 37,500 | — | D |
Explanation of responses
- F1This option vested 25% on October 6, 2016, and the remaining 75% vests in 36 monthly installments thereafter, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
- F2The option vests in 48 monthly installments over the four-year period which commenced on the last day of January 2016, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
- F3The option vests in 48 monthly installments over the four-year period which commenced on the last day of January 2017, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
- F4The option vests in 48 monthly installments over the four-year period which commenced on the last day of January 2018, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
Remarks
Exhibit 24 - Power of Attorney